Skip to Content
Søk Menu
Välkommen till lungcancer

Få de senaste artiklarna och MEDtalks om lungcancer.

Senaste nytt om lungcancer

Lung Cancer Insights: What’s New in the Field

  • / Jan Andreasen / Amanda Feldballe Bernholm

New Data Support Osimertinib as a Backbone Treatment for EGFRm Advanced NSCLC

/ Jan Andreasen
LungcancerNSCLCWCLC25
Pasi Jänne

New Class of Medicines Emerge as Potential Therapies in MTAP-Deleted NSCLC

/ Pasi Jänne
LungcancerNSCLCWCLC25 Play the Video
Michael Stenger

WCLC 2025: Lung Cancer Screening and Early Results from the Danish PLUS Trial

/ Michael Stenger
LungcancerWCLC25 Play the Video

Amivantamab + Lazertinib in EGFR-Mutated Advanced NSCLC: PALOMA-2 Update

/ Jan Andreasen
LungcancerNSCLCWCLC25

Första linjens NSCLC utan cancerdrivande mutationer: praktik, brister och kostnader

/ Ronny Öhman / Jan Andreasen
LungcancerNSCLC

New Treatment Possibilities Improve Future Outcomes of Lung Cancer

/ BestPractice Nordic
ESMO24Lungcancer

No Major Breakthroughs in Lung Cancer Compared to ESMO 2023

/ BestPractice Nordic
ESMO24Lungcancer
Load more

Artiklar

CheckMate 227: 6-year data on the treatment of locally advanced NSCLC with Opdivo and Yervoy  

/ BestPractice Nordic
LungcancerNSCLCWCLC23

Adjuvant treatment with 3rd generation EGFR-TKI can increase progression-free survival 

/ BestPractice Nordic
LungcancerNSCLCWCLC23

WCLC 2023 – NSCLC: New Data on Perioperative Immunotherapy Treatment 

/ BestPractice Nordic
ImmunterapiLungcancerNSCLCWCLC23

CheckMate 9LA – Investigating the role of immunotherapy combinations in patients with non-small cell lung cancer

/ Martin Reck
Lungcancer

New data: Potential improved overall survival for stage IV non-small cell lung cancer patients

Lungcancer

Vad har kroniskt obstruktiv lungsjukdom och lungcancer gemensamt?

/ Anna-Karin Larsson-Callerfelt
LungcancerLungsjukdom

WCLC I Kongresside

6.-9. september 2025

MEDtalks

Maria Silvoniemi

Clinical Dilemmas in the Management of NSCLC Without Driver Mutations

/ Maria Silvoniemi
LungcancerNSCLC Play the Video
Luis Paz-Ares

ASCO 2025: Lurbinectedin–Atezolizumab Improves Survival in SCLC

/ Luis Paz-Ares
ASCO25Lungcancer Play the Video
Miriam Grønberg

Treatment Timing Impacts Survival in Limited Stage Small Cell Lung Cancer

/ Miriam Grønberg
Lungcancer Play the Video
Karin Lindberg

Kliniska fördelar med stereotaktisk strålbehandling vid oligometastatisk non-small cell lungcancer, NSCLC

/ Karin Lindberg
LungcancerOnkologisk Forum 2024 Play the Video

Outstanding Results for the Treatment of Lung Cancer

/ Tony Mok
Lungcancer Play the Video
Edyta Maria Urbanska

New Tendencies in Development of ALK-TKIs for Treatment of ALK-Rearranged NSCLC

/ Edyta Maria Urbanska
Lungcancer Play the Video
Load more
Back to top